@article{quteprints28661,
           month = {January},
           title = {Does lymphedema following breast cancer warrant clinical attention?},
          author = {Sandra C.  Hayes and Beth M. Newman},
          volume = {8},
         journal = {The American Journal of Hematology/Oncology},
           pages = {39--40},
          number = {1},
       publisher = {Haymarket Media Inc.},
            year = {2009},
        abstract = {Secondary lymphedema (swelling) after breast cancer treatment usually develops on the hand, arm, shoulder, and/or breast on the treated side. It is commonly associated
with the presence of other upper-body symptoms, such as
pain and aching1; it impacts physical and psychosocial functioning and adversely influences quality of life.2 Moreover, it is considered incurable, progressive, and difficult to treat. Arguably, lymphedema is the most problematic and dreaded treatment-related complication of
breast cancer.3},
        keywords = {secondary lymphedema, breast cancer},
             url = {https://eprints.qut.edu.au/28661/}
}